Lv11
20 积分 2021-07-24 加入
Caution the arrhythmia association with antibody-drug conjugates: a pharmacovigilance study
3小时前
待确认
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
4小时前
已完结
Biomarkers for Predicting Cytokine Release Syndrome following CD19-Targeted CAR T Cell Therapy
15天前
已完结
Cytokine Release Syndrome By T-cell–Redirecting Therapies: Can We Predict and Modulate Patient Risk?
15天前
已完结
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report
1个月前
已完结
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
1个月前
已完结
Small Cell Lung Cancer
2个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
3个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
3个月前
已完结
皖公网安备34019202002308
